Dr. Stanley Receives World-Class Training in ICL Refractive Surgery, a Lens-Based LASIK Alternative
Dr. Jordan Stanley, board-certified ophthalmologist and owner of PureSight Surgical, completed advanced training in Implantable Collamer Lens (ICL) refractive surgery at the Zaldivar Institute in Mendoza, Argentina in November 2024.
ICL implants are placed in the eye, between the iris and the natural lens, to correct nearsightedness and astigmatism. Receiving world-class training in this technique enables Dr. Stanley to offer patients long-term vision correction safely and effectively for Marietta patients, in addition to our other ophthalmology services like cataract surgery and glaucoma management.
The Globally-Recognized Zaldivar Institute
The Zaldivar Institute is globally renowned for expertise in ICL surgery, and Dr. Stanley was among a select group of twelve international surgeons accepted to participate in the immersive ICL course.
The Advantages of ICL Surgery Over Traditional LASIK for Vision Correction
While LASIK is the most well-known refractive surgery to people in the United States, ICL offers several advantages over LASIK: It treats greater degrees of nearsightedness, preserves the corneal structure, provides UV protection, and is reversible. Additionally, patients often experience better night vision with fewer instances of halos or glares.
ICL corrects a greater degree of nearsightedness than LASIK, and does not worsen dry eye syndrome.
The procedure involves implanting a flexible collamer lens inside the eye to correct vision, without altering the corneal shape or removing corneal tissue. LASIK surgery reshapes the cornea and thus can exacerbate or initiate dry eye syndrome.
At PureSight Surgical, we provide transparent pricing and personalized care to save you both time and money. For patients who are un- or under-insured, this empowers you to understand what your care costs and avoid unexpected fees and charges.
The FDA-Approved EVO ICL Lenses
Dr. Stanley uses the latest generation of EVO ICL™ lenses, approved by the FDA in 2022, which provide UV protection and feature a central port that eliminates the need for peripheral iridotomies. With over 2 million ICLs implanted worldwide, the procedure has a proven track record of safety and success in offering freedom from glasses and contacts.
Are you interested in learning more about ICL surgery and whether you are a candidate? Visit our complete guide to ICL surgery or call (770) 230-2020 to schedule your consultation with Marietta ophthalmologist Dr. Stanley.